Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Taxane‐based chemohormonal therapy for metastatic hormone‐sensitive prostate cancer

Esta versión no es la más reciente

Información

DOI:
https://doi.org/10.1002/14651858.CD012816Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 30 septiembre 2017see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Urología

Copyright:
  1. Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Niranjan J Sathianathen

    Correspondencia a: Department of Urology, University of Minnesota, Minneapolis, USA

    [email protected]

  • Yiannis A Philippou

    Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK

  • Gretchen M Kuntz

    Borland Health Sciences Library, University of Florida‐Jacksonville, Jacksonville, USA

  • Badrinath R Konety

    Department of Urology, University of Minnesota, Minneapolis, USA

  • Alastair D Lamb

    Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK

  • Philipp Dahm

    Urology Section, Minneapolis VA Health Care System, Minneapolis, USA

Contributions of authors

NS: wrote the protocol.

YP: wrote the protocol.

GK: wrote the protocol.

BK: wrote the protocol.

AL: wrote the protocol.

PD: wrote the protocol.

Sources of support

Internal sources

  • University of Minnesota Department of Urology, USA.

    Partial salary support for Niranjan Sathianathen

External sources

  • No sources of support supplied

Declarations of interest

NS: none known.

YP: none known.

GK: none known.

BK: none known.

AL: none known.

PD: none known.

Acknowledgements

We thank the Cochrane Urology editorial team for their help and support.

Version history

Published

Title

Stage

Authors

Version

2018 Oct 15

Taxane‐based chemohormonal therapy for metastatic hormone‐sensitive prostate cancer

Review

Niranjan J Sathianathen, Yiannis A Philippou, Gretchen M Kuntz, Badrinath R Konety, Shilpa Gupta, Alastair D Lamb, Philipp Dahm

https://doi.org/10.1002/14651858.CD012816.pub2

2017 Sep 30

Taxane‐based chemohormonal therapy for metastatic hormone‐sensitive prostate cancer

Protocol

Niranjan J Sathianathen, Yiannis A Philippou, Gretchen M Kuntz, Badrinath R Konety, Alastair D Lamb, Philipp Dahm

https://doi.org/10.1002/14651858.CD012816

Notes

We have based parts of the Methods section of this protocol on a standard template developed by the Cochrane Metabolic and Endocrine Disorders Group, which has been modified and adapted for use by the Cochrane Urology Group.

Keywords

MeSH

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.